drugset / Trial / NCT02028104

Stem Cell Therapy in Traumatic Brain Injury

NCT02028104 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with Traumatic Brain Injury

Timeline

Start
2010-01
Primary completion
2016-04
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous bone marrow mononuclear cell transplantation Cell therapy — Intrathecal